Prenatal vitamin supplementation and pediatric brain tumors: Huge international variation in use and possible reduction in risk

Susan Preston-Martin, Janice M. Pogoda, Beth A. Mueller, Flora Lubin, Baruch Modan, Elizabeth A. Holly, Graziella Filippini, Sylvaine Cordier, Raphael Peris-Bonet, Won Choi, Julian Little, Annie Arslan

Research output: Contribution to journalArticle

Abstract

An international case-control study of primary pediatric brain tumors included interviews with mothers of cases diagnosed from 1976-1994 and mothers of population controls. Data are available on maternal vitamin use during pregnancy for 1051 cases and for 1919 controls in eight geographic areas of North America, Europe and Israel. While risk estimates varied by study center, combined results suggest that maternal supplementation for two trimesters may decrease risk of brain tumor [odds ratio (OR)=0.7; 95% confidence interval (CI)=0.50.9], with a trend toward less risk with longer duration of use (P trend= 0.0007). The greatest risk reduction was among children diagnosed under 5 years of age whose mothers used supplements during all three trimesters (OR=0.5; CI=0.3-0.8). This effect did not vary by histology and was seen for supplementation during pregnancy rather than during the month before pregnancy or while breast feeding. These findings are largely driven by data from the US, where most mothers took vitamins. The proportion of control mothers who took vitamins during pregnancy varied tremendously, from 3% in Israel and in France through 21% in Italy, 33% in Canada, 52% in Spain to 86-92% at the three US centers. The composition of the various multivitamin compounds taken also varied: daily dose of vitamin C ranged from 0 up to 600 mg; vitamin E from 0 to 70 mg; vitamin A from 0 to 30,000 IU and folate from 0 to 2000 mg. Mothers also took individual micronutrient supplements (e.g., vitamin C tablets), but most mothers who took these also took multivitamins, making it impossible to determine potential independent effects of these micronutrients.

Original languageEnglish
Pages (from-to)551-557
Number of pages7
JournalChild's Nervous System
Volume14
Issue number10
DOIs
Publication statusPublished - Oct 1998

Fingerprint

Risk Reduction Behavior
Vitamins
Brain Neoplasms
Mothers
Pediatrics
Pregnancy
Micronutrients
Israel
Ascorbic Acid
Odds Ratio
Confidence Intervals
Population Control
North America
Breast Feeding
Vitamin A
Vitamin E
Folic Acid
Spain
Italy
Tablets

Keywords

  • Brain neoplasms
  • Childhood neoplasms
  • Prenatal exposures
  • Vitamin supplements

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology

Cite this

Preston-Martin, S., Pogoda, J. M., Mueller, B. A., Lubin, F., Modan, B., Holly, E. A., ... Arslan, A. (1998). Prenatal vitamin supplementation and pediatric brain tumors: Huge international variation in use and possible reduction in risk. Child's Nervous System, 14(10), 551-557. https://doi.org/10.1007/s003810050271

Prenatal vitamin supplementation and pediatric brain tumors : Huge international variation in use and possible reduction in risk. / Preston-Martin, Susan; Pogoda, Janice M.; Mueller, Beth A.; Lubin, Flora; Modan, Baruch; Holly, Elizabeth A.; Filippini, Graziella; Cordier, Sylvaine; Peris-Bonet, Raphael; Choi, Won; Little, Julian; Arslan, Annie.

In: Child's Nervous System, Vol. 14, No. 10, 10.1998, p. 551-557.

Research output: Contribution to journalArticle

Preston-Martin, S, Pogoda, JM, Mueller, BA, Lubin, F, Modan, B, Holly, EA, Filippini, G, Cordier, S, Peris-Bonet, R, Choi, W, Little, J & Arslan, A 1998, 'Prenatal vitamin supplementation and pediatric brain tumors: Huge international variation in use and possible reduction in risk', Child's Nervous System, vol. 14, no. 10, pp. 551-557. https://doi.org/10.1007/s003810050271
Preston-Martin, Susan ; Pogoda, Janice M. ; Mueller, Beth A. ; Lubin, Flora ; Modan, Baruch ; Holly, Elizabeth A. ; Filippini, Graziella ; Cordier, Sylvaine ; Peris-Bonet, Raphael ; Choi, Won ; Little, Julian ; Arslan, Annie. / Prenatal vitamin supplementation and pediatric brain tumors : Huge international variation in use and possible reduction in risk. In: Child's Nervous System. 1998 ; Vol. 14, No. 10. pp. 551-557.
@article{f9b11eb8cc57417fbbf66c3b83e2c81d,
title = "Prenatal vitamin supplementation and pediatric brain tumors: Huge international variation in use and possible reduction in risk",
abstract = "An international case-control study of primary pediatric brain tumors included interviews with mothers of cases diagnosed from 1976-1994 and mothers of population controls. Data are available on maternal vitamin use during pregnancy for 1051 cases and for 1919 controls in eight geographic areas of North America, Europe and Israel. While risk estimates varied by study center, combined results suggest that maternal supplementation for two trimesters may decrease risk of brain tumor [odds ratio (OR)=0.7; 95{\%} confidence interval (CI)=0.50.9], with a trend toward less risk with longer duration of use (P trend= 0.0007). The greatest risk reduction was among children diagnosed under 5 years of age whose mothers used supplements during all three trimesters (OR=0.5; CI=0.3-0.8). This effect did not vary by histology and was seen for supplementation during pregnancy rather than during the month before pregnancy or while breast feeding. These findings are largely driven by data from the US, where most mothers took vitamins. The proportion of control mothers who took vitamins during pregnancy varied tremendously, from 3{\%} in Israel and in France through 21{\%} in Italy, 33{\%} in Canada, 52{\%} in Spain to 86-92{\%} at the three US centers. The composition of the various multivitamin compounds taken also varied: daily dose of vitamin C ranged from 0 up to 600 mg; vitamin E from 0 to 70 mg; vitamin A from 0 to 30,000 IU and folate from 0 to 2000 mg. Mothers also took individual micronutrient supplements (e.g., vitamin C tablets), but most mothers who took these also took multivitamins, making it impossible to determine potential independent effects of these micronutrients.",
keywords = "Brain neoplasms, Childhood neoplasms, Prenatal exposures, Vitamin supplements",
author = "Susan Preston-Martin and Pogoda, {Janice M.} and Mueller, {Beth A.} and Flora Lubin and Baruch Modan and Holly, {Elizabeth A.} and Graziella Filippini and Sylvaine Cordier and Raphael Peris-Bonet and Won Choi and Julian Little and Annie Arslan",
year = "1998",
month = "10",
doi = "10.1007/s003810050271",
language = "English",
volume = "14",
pages = "551--557",
journal = "Child's Nervous System",
issn = "0256-7040",
publisher = "Springer Verlag",
number = "10",

}

TY - JOUR

T1 - Prenatal vitamin supplementation and pediatric brain tumors

T2 - Huge international variation in use and possible reduction in risk

AU - Preston-Martin, Susan

AU - Pogoda, Janice M.

AU - Mueller, Beth A.

AU - Lubin, Flora

AU - Modan, Baruch

AU - Holly, Elizabeth A.

AU - Filippini, Graziella

AU - Cordier, Sylvaine

AU - Peris-Bonet, Raphael

AU - Choi, Won

AU - Little, Julian

AU - Arslan, Annie

PY - 1998/10

Y1 - 1998/10

N2 - An international case-control study of primary pediatric brain tumors included interviews with mothers of cases diagnosed from 1976-1994 and mothers of population controls. Data are available on maternal vitamin use during pregnancy for 1051 cases and for 1919 controls in eight geographic areas of North America, Europe and Israel. While risk estimates varied by study center, combined results suggest that maternal supplementation for two trimesters may decrease risk of brain tumor [odds ratio (OR)=0.7; 95% confidence interval (CI)=0.50.9], with a trend toward less risk with longer duration of use (P trend= 0.0007). The greatest risk reduction was among children diagnosed under 5 years of age whose mothers used supplements during all three trimesters (OR=0.5; CI=0.3-0.8). This effect did not vary by histology and was seen for supplementation during pregnancy rather than during the month before pregnancy or while breast feeding. These findings are largely driven by data from the US, where most mothers took vitamins. The proportion of control mothers who took vitamins during pregnancy varied tremendously, from 3% in Israel and in France through 21% in Italy, 33% in Canada, 52% in Spain to 86-92% at the three US centers. The composition of the various multivitamin compounds taken also varied: daily dose of vitamin C ranged from 0 up to 600 mg; vitamin E from 0 to 70 mg; vitamin A from 0 to 30,000 IU and folate from 0 to 2000 mg. Mothers also took individual micronutrient supplements (e.g., vitamin C tablets), but most mothers who took these also took multivitamins, making it impossible to determine potential independent effects of these micronutrients.

AB - An international case-control study of primary pediatric brain tumors included interviews with mothers of cases diagnosed from 1976-1994 and mothers of population controls. Data are available on maternal vitamin use during pregnancy for 1051 cases and for 1919 controls in eight geographic areas of North America, Europe and Israel. While risk estimates varied by study center, combined results suggest that maternal supplementation for two trimesters may decrease risk of brain tumor [odds ratio (OR)=0.7; 95% confidence interval (CI)=0.50.9], with a trend toward less risk with longer duration of use (P trend= 0.0007). The greatest risk reduction was among children diagnosed under 5 years of age whose mothers used supplements during all three trimesters (OR=0.5; CI=0.3-0.8). This effect did not vary by histology and was seen for supplementation during pregnancy rather than during the month before pregnancy or while breast feeding. These findings are largely driven by data from the US, where most mothers took vitamins. The proportion of control mothers who took vitamins during pregnancy varied tremendously, from 3% in Israel and in France through 21% in Italy, 33% in Canada, 52% in Spain to 86-92% at the three US centers. The composition of the various multivitamin compounds taken also varied: daily dose of vitamin C ranged from 0 up to 600 mg; vitamin E from 0 to 70 mg; vitamin A from 0 to 30,000 IU and folate from 0 to 2000 mg. Mothers also took individual micronutrient supplements (e.g., vitamin C tablets), but most mothers who took these also took multivitamins, making it impossible to determine potential independent effects of these micronutrients.

KW - Brain neoplasms

KW - Childhood neoplasms

KW - Prenatal exposures

KW - Vitamin supplements

UR - http://www.scopus.com/inward/record.url?scp=7844242880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7844242880&partnerID=8YFLogxK

U2 - 10.1007/s003810050271

DO - 10.1007/s003810050271

M3 - Article

C2 - 9840378

AN - SCOPUS:7844242880

VL - 14

SP - 551

EP - 557

JO - Child's Nervous System

JF - Child's Nervous System

SN - 0256-7040

IS - 10

ER -